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Abstract:  
Primary Immunodeficiencies (PID) are inherited conditions where components of the immune 
system are missing or dysfunctional. Over 300 genes have been causally linked to monogenic forms 
of PID, including a number that regulate the actin cytoskeleton. The majority of cytoskeletal defects 
disrupt assembly and disassembly of filamentous actin in multiple immune cell lineages impacting 
functions such as cell migration and adhesion, pathogen uptake, intercellular communication, 
intracellular signalling, and cell division. In the past 24 months, new actin defects have been 
identified through next generation sequencing technologies. Substantial progress has also been 
made in understanding the pathogenic mechanisms that contribute to immunological dysfunction, 
and also how the cytoskeleton participates in normal physiological immune processes. This review 
summarises recent advances in the field, raising awareness of these conditions and our current 
understanding of their presentation. Description of further cases and new conditions will extend the 
clinical phenotype of actin relation disorders, and will promote the development of more effective 
and targeted therapies.  
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Introduction 
The actin cytoskeleton is required for many immune cell functions including migration, adhesion, 
phagocytosis, assembly of complex intercellular contacts, and cell division. More recently, a 
contribution of the cytoskeleton to regulation of other cell processes such as receptor signalling, 
calcium flux and gene expression has been appreciated, highlighting the complex multi-layered role 
that it can play in host defence and immune homeostasis. In the most recent international 
classification, 10 different primary immunodeficiencies (PID) result from defects of cytoskeletal 
regulation.(1) In most cases these involve actin regulators that are restricted to haematopoietic cells, 
which is consistent with the observation that ubiquitously expressed actin regulators are 
embryonically lethal in mouse models.  Known cytoskeleton-associated PIDs present either as 
combined or severe combined immunodeficiencies (CID or SCID) or as phagocyte disorders. These 
monogenic conditions have taught us a great deal about the roles and regulation of actin in 
leukocytes. In this review, we will briefly summarise our current understanding of cytoskeletal 
disorders that cause PID in humans.  
Regulation of the actin cytoskeleton 
Dynamic rearrangement of cell shape required for motility, adhesion, particle uptake and cell 
division relies on rapid assembly and disassembly of filamentous actin ( F-actin, Figure 1). In steady 
state, F-actin polymerisation occurs spontaneously, however, the initial nucleation step, which 
involves the formation of G-actin dimers and trimers, is thermodynamically unfavourable (2). For 
this reason, various actin nucleators exist which promote nucleation, generally in response to 
specific upstream signals such as integrin activation, T and B-cell receptor ligation and chemokine 
stimulation. The three known families of actin nucleators are formins, Arp2/3 complex and WASp 
homology (WH2) domain-containing proteins, although the latter may only play an auxiliary role and 
require synergy with other factors (3). Each of the classes is differentially regulated and differs in the 
mechanism of action (4). Formin activity results in the generation of new unbranched filaments, 
which are typically associated with filopodial structures (5) while Arp2/3 complex activity results in 
the formation of a dense branched actin network such as that found behind the leading edge of 
migrating cells (6). Arp2/3 itself is a weak nucleator and requires activation by nucleation-promoting 
factors, such as those belonging to the Wiskott-Aldrich protein (WASp) family (7). In addition to 
activating the Arp2/3 complex, WASp-family members play a critical role in integrating different 
signals for cytoskeletal arrangement through their domain structure that enables interaction with 
many partners, including Rho family GTPases, phosphoinositide lipids at the plasma membrane and 
kinases (8). Negative regulation of F-actin assembly is equally important for normal cytoskeletal 
dynamics and this is achieved by several mechanisms including capping and severing of actin 
filaments. 
Combined and Severe combined immunodeficiencies 
Many haematopoietic actin regulators are expressed from early stages of cell stem differentiation 
and thus alterations in their function impact multiple immune lineages resulting in combined defects 
of humoral and cellular immunity. These are often clinically severe and most warrant correction by 
haematopoietic stem cell transplantation or gene therapy. The haematopoietic actin regulators 
described in this review are summarised in Figure 2.  
Wiskott Aldrich Syndrome (WAS)  
WAS is the best characterised PID resulting from defects of the actin cytoskeleton and remains the 
archetypical example in the field. Loss of function mutations in the WAS gene disrupt expression and 
function of the hematopoietically-restricted WAS protein (WASp) resulting in failure of Arp2/3-
mediated actin polymerisation. In classical WAS, where WASp expression is typically completely 
absent, a combined defect of innate and adaptive immunity is associated with 
microthrombocytopoenia, eczema, haematological malignancies and a very elevated risk of 
autoimmunity (9). A milder phenotype also exists (previously called X-linked thrombocytopenia), 
associated with preservation WASp expression, and although thrombocytopenia can be severe, 
immunological abnormalities are much less prominent. Interestingly, gain of function mutations 
result in a completely different phenotype characterised by congenital neutropenia (10). 
The broad immunodeficiency seen in severe WAS is explained by widespread disruption of lymphoid 
and myeloid lineage immune cell functions including cell spreading, migration, phagocytosis and 
immune synapse assembly (reviewed in Burns and Thrasher NRI).  Substantial progress has been 
made in understanding the role of WASp in myeloid cells and T cells for induction of T-cell responses. 
Recently, it was also shown that defects of dendritic cells and T-cells also result in inflammatory 
complications, in particular WAS-associated eczema. In an elegant study using WAS murine models, 
skin inflammation was demonstrated to result from a combination of failure of Langerhan cells to 
emigrate from the skin to lymph nodes and enhanced cross presentation of exogenous antigen 
resulting in ectopic activation of CD8 T-cells(11). Surprisingly, a major factor driving aberrant cross 
presentation is reduced acidification of phagolysosomes in WASp-deficient DC as a result of 
upregulated RAC2 activity in the absence of WASp. This highlights how altered function of other 
cytoskeletal molecules in the absence of normal WASp causes some features of the clinical disease. 
A number of recent papers have highlighted the complex role of WASp in B-cells that may differ at 
varying stages of B-cell maturation. There is now a body of evidence demonstrating that WASp-
mediated actin rearrangement is necessary for BCR clustering and subsequent signalling. In memory 
B-cells, WASp-deficiency causes impaired spreading and B-cell receptor (BCR) clustering which 
directly impairs BCR signalling (12). Memory B-cell activation is further disrupted by reduced 
transcription of the BCR co-receptor CD19, loss of CD19 recruitment of CD19 to the BCR and 
enhanced recruitment of the BCR negative regulators FCyRIIB and SHIP. The combined impact on 
memory B-cell function presumably contributes to poor antibody responses. In contrast, however, 
several studies have demonstrated modestly enhanced BCR responsiveness in WASp-deficient 
immature B-cells (13-16). It is not clear why WASp exerts different effects on BCR signalling in 
immature and mature B-cells but the effect in immature cells may make a significant contribution to 
the development of antibody mediated autoimmunity in WAS. WAS-deficient mice and humans 
demonstrate positive selection of self-reactive B-cells in mature naive B-cell populations, especially 
marginal zone B-cells (MZB). This appears to be driven by abnormally enhanced signalling through 
both the BCR and MyD88-dependent toll-like receptors, suggesting a role for WASp in regulation of 
these pathways to preserve self-tolerance. In addition to altering repertoire, excessive BCR and TLR7 
signalling in WAS-deficient MZB cells promotes their egress from the MZ (15), resulting in loss of 
MZB cells in spleens of mice which is likely to additionally impact pathogen responses.  It seems 
likely that altered antibody production in WAS is not only due to intrinsic B-cell defects. For example, 
follicular T helper cells (Tfh) play a key role in regulation B-cell antibody production in germinal 
centres (GC) which are poorly formed in WAS. In keeping with this observation, it was recently 
reported that circulating Tfh cells are reduced in patients and mice with WAS (17)as a result of 
reduced proliferation, increased apoptosis and altered differentiation associated with poor 
expression of the Tfh transcription factor BCL6.  
It has been postulated that some functions of WASp are compensated for by other WASp family 
members, in particular the ubiquitously expressed homologue, N-WASp. Conditional knock out mice 
(in which either WASp alone or WASp and N-WASp are deleted) have revealed some important 
information about the interaction of WASp and N-WASp for B-cell function (18, 19). Additional 
deletion of N-WASp in WASp-deficient B-cells further impairs B-cell proliferation, GC formation and 
T-dependent antibody responses indicating that N-WASp partially preserves these functions in WAS. 
Paradoxically, however, additional deletion of N-WASp reduces IgG autoantibodies and abrogates 
antibody-mediated autoimmunity suggesting that unopposed activity of N-WASp in WASp-deficient 
B-cells is an important factor in the development of IgG antibody-mediated autoimmunity. This is 
relevant for patients as auto-antibody production is prevalent in both severe and mild forms of WAS 
(20) and N-WASp may represent a novel therapeutic target for problematic WAS-associated 
autoimmune disease.  
WASp-interacting protein (WIP)- deficiency 
Normal function of WASp depends heavily on interaction with other signalling molecules such as 
WIP which plays an important role in regulating WASp activation and degradation (21). Rare 
autosomal recessive WIP-deficiency disrupts normal WASP-WIP interactions resulting in severe 
reduction of cytosolic WASp(22). The cellular impact is very similar to WASp-deficiency with a more 
profound defect of T-cell proliferation, activation and migration compatible with additional WASp-
independent functions of WIP. As very few patients with WIP-deficiency have been described, most 
information about the functional consequence of WIP-deficiency comes from WIP-knockout mice 
where, in addition to T-cell dysfunction, defects of dendritic cell podosome assembly and migration 
as well as B-cell migration and CD19-mediated B-cell activation have been described (21, 23, 24).  
DOCK8 deficiency 
DOCK8 is a member of the DOCK family of guanine nucleotide exchange factors (GEFs) that is widely 
expressed and functions to regulate small G proteins including the WASp-activator CDC42. In 
humans DOCK8-deficiency gives rise to an autosomal recessive combined immune deficiency 
originally considered to be a form of Hyper-IgE syndrome  (25, 26). Description of the largest cohort 
of 64 patients highlight a broad susceptibility to bacterial viral and fungal infections with variable 
lymphopenia and functional antibody responses (27). As DOCK8 plays a role in phosphorylation and 
translocation of STAT3 to the nucleus (28) it is not surprising that this condition overlaps significantly 
with hyper-IgE syndrome caused by autosomal dominant mutations in STAT3 where similar defects 
of STAT3-dependent gene expression and Th17 differentiation are evident. Despite this, DOCK8-
deficient patients lack a number of the typical extra haematopoietic features of STAT3 deficiency 
(27). 
DOCK8 regulates the cytoskeleton in both myeloid and lymphoid lineages. Interestingly the impact of 
DOCK8 deficiency on cell migration is subtle compared WASp deficiency, mainly impacting T cells, 
NK-cells and dendritic cells (29, 30). Naive CD8 T cells are diminished and exhausted in peripheral 
blood of patients with DOCK8 deficiency and formation of the CD8 T cell immune synapse is 
impaired (31).  Defects of shape and nuclear deformation lead to cell death termed cytothripsis and 
failure to generate long-lived skin resident memory CD8 T cells which may contribute to herpes viral 
skin infections  (30). Similar to WASp, DOCK8 plays a role in B-cell activation particularly following 
TLR-9 ligation (32). T and B-cell defects are likely to be partly responsible for autoimmune 
manifestations as DOCK8 deficiency reduces the number and function of regulatory T cells and 
impairs late B-cell tolerance checkpoints resulting in enrichment of autoreactive B cells in mature 
naive B-cell compartments (33). DOCK8 has also been shown to be important for the survival and 
function of a number of innate immune cell subsets including classify to dendritic cells innate 
lymphoid cells, NK and NK T cells)(34-36), highlighting the breadth of the DOCK8-associated 
immunodeficiency.  
 
DOCK2 deficiency 
DOCK2 is a member of the DOCK-A subfamily and one of the major GEFs for Rac. Recently five 
unrelated patients were reported with combined immune deficiency caused by biallelic loss of 
function mutations in DOCK2 (37). Patients are markedly susceptible to bacterial, viral, 
mycobacterial and opportunistic infections including vaccine-strain viruses. T-cell lymphopenia and T 
cell proliferative responses were universally impaired and associated with reduced Rac activation 
after anti-CD3 stimulation. Total F actin content and chemotaxis were impaired in T and B cells 
associated with variable reduction in naive T cell and B cell numbers and functional antibody 
responses. Defects were also seen in NK cell actin polymerisation and degranulation, circulating NK T 
cell numbers, interferon alpha and lambda production by peripheral blood mononuclear cells and 
viral susceptibility of patient fibroblasts indicating a broad defect of innate immunity. DOCK2-/- mice 
also demonstrate defects of neutrophil chemotaxis and superoxide production (38) but these remain 
to be investigated in humans. 
Moesin (MSN) deficiency 
Recently hemizygous mutations in the moesin (MSN) gene were identified in seven boys from five 
different families giving rise to a novel X-linked combined immune deficiency characterised by 
defects of T-cell function associated with hypogammaglobulinaemia (39). MSN belongs to the ezrin, 
MSN, radixin (ERM) family of proteins that link actin filaments to the plasma membrane, and is 
important for cellular rigidity and polarisation and signalling from some surface receptors. Affected 
individuals suffered from recurrent bacterial infections, mainly of the respiratory tract, along with 
unusually severe varicella-zoster infections and molluscum contagiosum. Autoimmunity in the form 
of alopecia or autoantibodies leading to thrombotic thrombocytopenia purpura was seen in three 
patients. Curiously while MSN expression was significantly reduced in T and B cells, expression was 
preserved in granulocytes, monocytes and platelets. The reasons for this are not clear particularly as 
non-random X inactivation in female carriers was seen in both mononuclear and polymorphonuclear 
cells suggesting that the mutation impacts function in both myeloid and lymphoid lineages. The 
authors suggest that loss of MSN expression may increase over time or following cell activation and 
therefore be more prominent in long-lived lymphocytes. Impact on cellular function was 
demonstrated in T cells where MSN deficiency results in impaired proliferation after activation, 
upregulated adhesion and defective migration. Although numbers of circulating neutrophils, B cells 
and NK cells are reduced, the impact of MSN mutations on the function of these cell lineages 
remains to be investigated.  
Other PID that impact cytoskeletal function 
A number of other PID have been described arising from mutation in genes that are not directly 
involved in regulation of F-actin but impact specific actin-mediated responses. For example, CID 
resulting from loss of function mutations in MST1 (also known as STK-4) is associated with reduced 
adhesion and chemotaxis of lymphocytes in response to CXCL11 (40),  in keeping with a known role 
for MST1 in mediating ‘inside-out signals’ from chemokines to LFA-1 integrin activation in murine 
lymphocytes (41). In mice, at least, this has been shown to result in hypoplastic lymphoid tissue and 
reduced thymic egress (41), reminiscent of Coronin-1A-deficiency (42). 
Leukocyte adhesion defects (LADs) 
Life-threatening bacterial infections in infancy associated with neutrophilia are the hallmark of LADs 
which impair both leukocyte adhesion and migration.  LAD1,2 and 3 have been well documented 
(43) and will not be discussed here. LAD IV has been proposed as a classification for Rac2-
deficiency,(44) a very rare autosomal recessive disorder in which loss of function Rac2 mutations 
cause defects of neutrophil F-actin assembly, adhesion and migration resulting in neutrophilia and 
devastating bacterial infection. Compared with other LAD, Rac2 has the added feature of reduced 
respiratory burst consistent with the role of Rac2 as a component of the NADPH oxidase complex. 
Even though MST1 is known to regulate LFA-1 activation and bacterial infections are a component of 
MST1-deficiency, no significant defects of neutrophil function have been reported in this condition 
and neutrophilia is not a feature (45).  
MKL1-deficiency 
Severe neutrophil dysfunction and recurrent serious bacterial infection caused by loss of function 
mutations in Megakaryoblastic leukaemia 1 (MKL1) has recently been described.(46) MKL1 is a 
member of the myocardin -related transcription factor (MTRF) family of proteins that regulate actin 
dynamics. In the inactive state they are sequestered in a cytosolic complex with G actin which is 
decoupled by Rho GTPase stimulation to release actin monomers for filament formation. MKL1 then 
shuttles to the nucleus where it stimulates Serum Response Facor (SRF)- mediated transcription of 
actin and actin cytoskeleton-related genes. MKL1 deficiency in mice is known to disrupt 
megakaryocyte maturation and migration resulting in thrombocytopenia (47, 48). The function of 
immune cells in MKL1-deficient mice and the functional consequences for adaptive immunity remain 
to be investigated. 
Loss of MKL1 expression in humans significantly reduces the total levels of F-actin in both lymphoid 
and myeloid lineage immune cells and alters the expression of multiple cytoskeleton-related genes. 
This resulted in a significant reduction of both phagocytosis and migration of neutrophils in keeping 
with the clinical phenotype. In addition, cytoskeletal defects were observed in monocyte derived 
dendritic cells and fibroblasts from the patient indicating a wider role for MKL1 in immune 
regulation and possibly wound healing. Although only mild and intermittent thrombocytopenia was 
apparent in the affected patient, description of additional cases will be important to further 
elucidate the hematopoietic and extra haematopoietic disease phenotype. 
Conclusion 
Although defects of the actin cytoskeleton still account for a relatively small number of PIDs, a 
number of additional defects have been recently identified through wider availability of genetic 
sequencing. Variability in clinical phenotype can be explained by their different biological functions 
and patterns of gene expression, and characterisation of more patients affected by individual 
cytoskeletal gene mutations will provide important information for development of tailored 
therapies. Moreover, these new discoveries provide a unique insight into the biology of the actin 
cytoskeleton in human immune function and homeostasis. 
Key points: 
 Mutations in multiple genes encoding regulators of the actin cytoskeleton are known to 
cause PID 
 The majority of known actin-associated PID present as combined, or severe combined, 
immunodeficiency or as phagocyte disorders 
 The functions of multiple immune cell lineages are impaired in actin associated-PID 
 These conditions are important to inform our understanding of normal actin regulation in 
human immune cell lineages 
 Autoimmunity is a feature of some- actin associated PID and these conditions provide insight 
into general mechanisms of autoimmune disease 
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Figure Legends 
Figure 1: F-actin assembly 
Actin polymerisation is initiated when signals from cell membrane receptors and phospholipids 
activate Rho GTPase and WASp- family proteins. Nucleating proteins such as Arp 2/3 are recruited to 
initiate assembly of actin filaments from monomers; this reaction is promoted by profilin that 
complexes with actin monomers (G-actin) in the cytosol and converts G-actin-bound ADP to ATP. 
Further regulation is provided by capping proteins and severing proteins including ADF/cofilin. 
 
Figure 2: PID-associated actin regulators  
Multiple regulators of the actin cytoskeleton are implicated in primary immunodeficiency, mainly as 
a result of loss of function mutations in their encoding genes. The main regulators discussed in this 
review are shown here. DOCK proteins are activated by signals from the plasma membrane and 
function to convert inactive GDP-bound Rho family proteins to active GTP-bound forms. Rho-family 
proteins in turn activate other proteins including the actin nucleator Arp2/3 (directly and through 
WASp). MKL1 both regulates the pool of actin monomers available for filament assembly and gene 
expression of other actin-regulators. ERM and Coronin Type 1 proteins play important roles in linking 
assembled actin filaments to the plasma membrane for cortical rigidity and membrane protrusion. 
Mutations in integrins and their signalling partners MST1 and Kindlin-3 impair outside-in and inside-
out signalling which regulates f-actin assembly and dynamics in response to environmental cues.  
Abbreviations: ERM, ezrin radixin moesin family; Cor1, Coronin Type I family; ARP, Arp 2/3 complex; 
WASP, Wiskott-Aldrich Syndrome protein; WIP, WASp-interacting protein. 
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